Circulating Non-coding RNAs and Cardiovascular Diseases

Adv Exp Med Biol. 2020:1229:357-367. doi: 10.1007/978-981-15-1671-9_22.

Abstract

The discovery of noncoding RNAs (ncRNAs) including short microRNAs, long ncRNAs and circular RNAs has broaden our knowledge about mammalian genomes and transcriptomes. A growing number of evidence on aberrantly regulated ncRNAs in cardiovascular diseases has indicated that ncRNAs are critical contributors to cardiovascular pathophysiology. Moreover, multiple recent studies have reported that ncRNAs can be detected in the bloodstream that differs between health subjects and diseased patients and some of them are remarkably stable. Although our knowledge about the origin and function of the circulating ncRNAs is still limited, these molecules have been regarded as promising noninvasive biomarker for risk stratification, diagnosis and prognosis of various cardiovascular diseases. In this chapter, we have described biological characteristics of circulating ncRNAs and discussed current trends and future prospects for the usage of circulating ncRNAs as biomarkers for common cardiovascular diseases.

Keywords: Biomarker; Cardiovascular diseases; Heart diseases; Non-coding RNAs.

Publication types

  • Review

MeSH terms

  • Animals
  • Biomarkers / blood
  • Cardiovascular Diseases / blood*
  • Cardiovascular Diseases / genetics*
  • Humans
  • MicroRNAs / blood
  • RNA, Long Noncoding / blood
  • RNA, Untranslated / blood*

Substances

  • Biomarkers
  • MicroRNAs
  • RNA, Long Noncoding
  • RNA, Untranslated